Rhino 5 Plus
Finding published by the FDA
Finding published by the FDA
Finding date: 16 November 2013.
Undeclared desmethylcarbondenafil and dapoxetine
- FDA finding date
- 16 November 2013
- Company
- name not reproduced (no recognised company form)
- Subject published by the FDA
- Undeclared desmethylcarbondenafil and dapoxetine
- Published action
- Recall
- Programme
- Drugs
This official finding is dated and does not necessarily describe the product currently sold under this name. It does not constitute an analysis of its complete composition.
The subject and action are reproduced as published by the FDA, without generalisation to all batches or other products from the company.
Substances named in the FDA finding
| Published name | Published text and quantity | Recognised ingredient | Role or context |
|---|---|---|---|
| desmethylcarbondenafil | Undeclared desmethylcarbondenafil and dapoxetine | Not recognised | Substance named by the FDA |
| dapoxetine | Undeclared desmethylcarbondenafil and dapoxetine | Not recognised | Substance named by the FDA |
Substances named in the FDA finding do not constitute a complete composition. No quantity or dose is inferred.
Public register data after personal data protection
[
{
"action": "Recall",
"company": "nom non repris (aucune forme de société reconnue)",
"date": "2013-11-16",
"fda_urls": [
"https://wayback.archive-it.org/7993/20170112140813/http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2013/ucm375549.htm"
],
"outcome": "",
"product": "Rhino 5 Plus",
"program": "Drugs",
"source": "n/a",
"subject": "Undeclared desmethylcarbondenafil and dapoxetine"
}
]Official source
Food and Drug Administration, Health Fraud Product Database. Constats officiels datés.
Domaine public (politique du site FDA)
No ingredient list for this product yet. Have it to hand? Photograph the ingredient list.
Has the product changed? Photograph the packaging.